- Country: Czech Republic
- Summary: Emtricitabine, Tenofovir-Alafenamide and Bictegravir
- CZT Ref No: 98752488
- Deadline: 16 Apr 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: CZK 83603988
- Notice Type: Tender
- Document Ref. No.: 155301-2024
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The subject of this public contract is the continuous supply of a medicinal product containing the medicinal substance bictegravir, emtricitabine and tenofovir-alafenamide fumarate for the needs of the Central Military Hospital - Military Faculty Hospital Prague in accordance with the tender conditions.
Emtricitabine, tenofovir alafenamide and bictegravir
Doc Title: Emtricitabin, tenofovir-alafenamid a biktegravir
Contract Type: supplies - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINEmtricitabine, Tenofovir-Alafenamide and Bictegravir - Czech Tender
The CENTRAL MILITARY HOSPITAL - MILITARY UNIVERSITY HOSPITAL PRAGUE, a Government sector organization in Czech Republic, has announced a new tender for Emtricitabine, Tenofovir-Alafenamide and Bictegravir. This tender is published on CzechTenders under CZT Ref No: 98752488 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-04-16.
The estimated tender value is CZK 83603988, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
